Monsanto  (MON)  shares were in focus Wednesday after reporting a profit of $0.07 a share, while analysts had expected a loss of $0.03.
Revenue for its most recent quarter stood at $2.56 billion, topping Wall Street's estimates of $2.36 billion.
Last month, the company agreed to be acquired by Germany-based Bayer in a deal valued at $66 billion.
TheStreet's Scott Gamm reports from Wall Street